Yamagata, Akira http://orcid.org/0000-0001-6941-7152
Arita, Machiko
Tachibana, Hiromasa
Tokioka, Fumiaki
Sugimoto, Chikatoshi
Sumikawa, Hiromitsu
Tanaka, Tomonori
Yasui, Hideki http://orcid.org/0000-0002-7134-3364
Fujisawa, Tomoyuki http://orcid.org/0000-0002-8809-1781
Nakamura, Yutaro
Suda, Takafumi
Ishida, Tadashi
Article History
Received: 13 October 2020
Accepted: 18 April 2021
First Online: 20 April 2021
Declarations
:
: This study was approved by the institutional review boards of Kurashiki Central Hospital, Kurashiki, Japan (approval no. 3025) and Hamamatsu University School of Medicine, Hamamatsu, Japan (approval no. 19-042). The need for informed consent was waived due to the retrospective nature of the study.
: Not applicable.
: T.S. has received honoraria from Boehringer Ingelheim. T.I. has received honoraria from MSD. T.S. received research funds from Novartis, Ono, and AstraZeneca. T.S. received grants from Astellas, Ono, Daiichi Sankyo, Taiho, Takeda, Novartis, Pfizer, Boehringer Ingelheim, and MSD. The other authors have no conflicts of interests to disclose.